| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,797 |
1,763 |
$312K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,506 |
1,454 |
$51K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,268 |
1,058 |
$45K |
| 80053 |
Comprehensive metabolic panel |
5,643 |
4,450 |
$32K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,078 |
1,028 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,043 |
999 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,491 |
4,006 |
$19K |
| 87040 |
|
1,063 |
821 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
507 |
451 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,277 |
2,070 |
$12K |
| 83735 |
|
3,330 |
1,854 |
$12K |
| 83690 |
|
3,329 |
2,886 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
432 |
299 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
446 |
433 |
$10K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
150 |
131 |
$10K |
| 83605 |
|
1,778 |
1,271 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
184 |
152 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,796 |
956 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
351 |
275 |
$8K |
| 84484 |
|
1,792 |
1,478 |
$8K |
| 85379 |
|
1,525 |
1,403 |
$6K |
| 82948 |
|
2,448 |
1,006 |
$6K |
| 87430 |
|
686 |
656 |
$5K |
| 81003 |
|
3,395 |
3,181 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
525 |
496 |
$4K |
| 83880 |
|
406 |
334 |
$4K |
| 80306 |
|
651 |
593 |
$4K |
| 87186 |
|
619 |
577 |
$4K |
| 81001 |
|
1,973 |
1,805 |
$3K |
| 87510 |
|
231 |
223 |
$3K |
| 87480 |
|
231 |
223 |
$3K |
| 84702 |
|
504 |
409 |
$2K |
| 86140 |
|
938 |
813 |
$2K |
| 81025 |
|
850 |
819 |
$2K |
| 87507 |
|
12 |
12 |
$2K |
| 85610 |
|
875 |
629 |
$2K |
| 87660 |
|
247 |
236 |
$2K |
| 82962 |
|
1,058 |
582 |
$2K |
| 85027 |
|
508 |
312 |
$2K |
| 84439 |
|
352 |
325 |
$2K |
| 84703 |
|
354 |
325 |
$1K |
| 80061 |
Lipid panel |
304 |
284 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
186 |
172 |
$573.36 |
| 85651 |
|
247 |
227 |
$570.40 |
| 88307 |
|
12 |
12 |
$549.72 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
86 |
84 |
$379.66 |
| 86038 |
|
43 |
43 |
$339.70 |
| 88342 |
|
13 |
12 |
$293.22 |
| 84100 |
|
106 |
52 |
$251.94 |
| 87807 |
|
45 |
45 |
$226.35 |
| 86800 |
|
37 |
37 |
$212.40 |
| 82077 |
|
14 |
12 |
$145.04 |
| 81015 |
|
110 |
107 |
$138.86 |
| 85730 |
|
32 |
24 |
$91.28 |
| 82565 |
|
38 |
37 |
$86.21 |
| 87205 |
|
33 |
25 |
$61.25 |
| 80320 |
|
18 |
14 |
$0.00 |